Recent Advances in the Discovery of Novel Drugs on Natural Molecules, Second Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 72
Special Issue Editors
Interests: food proteins; bioactive peptides; natural antimicrobials; biofilms; bacterial physiology; proteomics
Special Issues, Collections and Topics in MDPI journals
Interests: microbiology; biotechnology; antibiotics; fermentation; natural compounds
Special Issues, Collections and Topics in MDPI journals
Interests: computer-aided drug design; predictive toxicology; chemoinformatics; artificial intelligence; digital platforms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With this Special Issue, we intend to collect all contributions regarding the discovery of new natural molecules with biological activity for therapeutic aims. Since drug discovery is still one of the fundamental pillars of modern medicine, the urgency in seeking new natural compounds or reusing old drugs for new therapeutic solutions is always a current topic. In this regard, the application of synthetic biology with all its multidisciplinary aspects (bioinformatics, data mining, pathway refactoring, cell factories, DNA editing, and computational chemistry) allows for the revelation of novel drug molecules from microbial strains or bioresources that might otherwise escape notice when using classical top-down strategies. Here, with this Special Issue, we wish to make such studies visible and open new pathways toward the more efficient and targeted enhancement of natural compounds for drug development.
Dr. Laura Quintieri
Dr. Leonardo Caputo
Prof. Dr. Orazio Nicolotti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural compounds
- bioactive peptides
- peptidomimetics
- microbial metabolites
- polyphenols
- genome mining
- molecular modeling
- therapeutic uses
